Article Information
vol. 9 no. 413
- Received for publication June 15, 2017
- Accepted for publication September 25, 2017
- .
Author Information
- Yoriko Saito1,
- Yoshiki Mochizuki2,
- Ikuko Ogahara1,
- Takashi Watanabe2,
- Leah Hogdal3,
- Shinsuke Takagi4,
- Kaori Sato1,
- Akiko Kaneko1,
- Hiroshi Kajita1,
- Naoyuki Uchida4,
- Takehiro Fukami5,
- Leonard D. Shultz6,
- Shuichi Taniguchi4,
- Osamu Ohara2,7,
- Anthony G. Letai3 and
- Fumihiko Ishikawa1,*
- 1Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
- 2Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
- 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- 4Department of Hematology, Toranomon Hospital, Tokyo 105-8470, Japan.
- 5RIKEN Program for Drug Discovery and Medical Technology Platforms, Yokohama, Kanagawa 230-0045, Japan.
- 6The Jackson Laboratory, Bar Harbor, ME 04609, USA.
- 7Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
- ↵*Corresponding author. Email: fumihiko.ishikawa{at}riken.jp